Literature DB >> 20589372

Ristocetin-induced self-aggregation of von Willebrand factor.

Massimiliano Papi1, Giuseppe Maulucci, Marco De Spirito, Mauro Missori, Giuseppe Arcovito, Stefano Lancellotti, Enrico Di Stasio, Raimondo De Cristofaro, Alessandro Arcovito.   

Abstract

Von Willebrand factor (VWF) is a large multimeric adhesive glycoprotein, with complex roles in thrombosis and hemostasis, present in circulating blood and in secretory granules of endothelial cells and platelets. High shear stress triggers conformational changes responsible for both binding to the platelet receptor glycoprotein GpIb and its self-association, thus supporting the formation of platelet plug under flow. Ristocetin also promotes the interaction of VWF with GpIb and is able to induce platelet aggregation, and thus is largely used to mimic this effect in vitro. In this research paper, we followed the time course of VWF self-association in solution induced by ristocetin binding by light scattering and at the same time we collected atomic force microscopy images to clarify the nature of the assembly that is formed. In fact, this process evolves initially through the formation of fibrils that subsequently interact to form supramolecular structures whose dimensions would be capable of trapping platelets even in the absence of any degree of shear stress or interaction with external surfaces. This intrinsic property, that is the ability to self-aggregate, may be involved in some pathological settings that have been revealed in clinical practice.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20589372     DOI: 10.1007/s00249-010-0617-8

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   1.733


  33 in total

Review 1.  3D domain swapping: as domains continue to swap.

Authors:  Yanshun Liu; David Eisenberg
Journal:  Protein Sci       Date:  2002-06       Impact factor: 6.725

2.  Functional self-association of von Willebrand factor during platelet adhesion under flow.

Authors:  Brian Savage; Jan J Sixma; Zaverio M Ruggeri
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

3.  Shear-dependent changes in the three-dimensional structure of human von Willebrand factor.

Authors:  C A Siedlecki; B J Lestini; K K Kottke-Marchant; S J Eppell; D L Wilson; R E Marchant
Journal:  Blood       Date:  1996-10-15       Impact factor: 22.113

4.  Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-Von Willebrand factor bound to the subendothelium.

Authors:  K S Sakariassen; P A Bolhuis; J J Sixma
Journal:  Nature       Date:  1979-06-14       Impact factor: 49.962

5.  Interaction of von Willebrand factor domain A1 with platelet glycoprotein Ibalpha-(1-289). Slow intrinsic binding kinetics mediate rapid platelet adhesion.

Authors:  S Miura; C Q Li; Z Cao; H Wang; M R Wardell; J E Sadler
Journal:  J Biol Chem       Date:  2000-03-17       Impact factor: 5.157

6.  The von Willebrand factor self-association is modulated by a multiple domain interaction.

Authors:  H Ulrichts; K Vanhoorelbeke; J P Girma; P J Lenting; S Vauterin; H Deckmyn
Journal:  J Thromb Haemost       Date:  2005-03       Impact factor: 5.824

7.  Initiation of platelet adhesion by arrest onto fibrinogen or translocation on von Willebrand factor.

Authors:  B Savage; E Saldívar; Z M Ruggeri
Journal:  Cell       Date:  1996-01-26       Impact factor: 41.582

Review 8.  Shear stress and von Willebrand factor in health and disease.

Authors:  Han-Mou Tsai
Journal:  Semin Thromb Hemost       Date:  2003-10       Impact factor: 4.180

Review 9.  Biochemistry and genetics of von Willebrand factor.

Authors:  J E Sadler
Journal:  Annu Rev Biochem       Date:  1998       Impact factor: 23.643

Review 10.  The presence of active von Willebrand factor under various pathological conditions.

Authors:  Evelyn Groot; Philip G de Groot; Rob Fijnheer; Peter J Lenting
Journal:  Curr Opin Hematol       Date:  2007-05       Impact factor: 3.284

View more
  6 in total

1.  Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D'D3 and D4 domains.

Authors:  Monica Sacco; Stefano Lancellotti; Mattia Ferrarese; Francesco Bernardi; Mirko Pinotti; Maira Tardugno; Erica De Candia; Leonardo Di Gennaro; Maria Basso; Betti Giusti; Massimiliano Papi; Giordano Perini; Giancarlo Castaman; Raimondo De Cristofaro
Journal:  Blood Adv       Date:  2020-07-28

2.  The thermal structural transition of alpha-crystallin modulates subunit interactions and increases protein solubility.

Authors:  Giuseppe Maulucci; Marco De Spirito; Giuseppe Arcovito; Massimiliano Papi
Journal:  PLoS One       Date:  2012-02-07       Impact factor: 3.240

3.  Staphylococcus aureus iron-regulated surface determinant B (IsdB) protein interacts with von Willebrand factor and promotes adherence to endothelial cells.

Authors:  Mariangela J Alfeo; Anna Pagotto; Giulia Barbieri; Timothy J Foster; Karen Vanhoorelbeke; Vincenzo De Filippis; Pietro Speziale; Giampiero Pietrocola
Journal:  Sci Rep       Date:  2021-11-23       Impact factor: 4.379

Review 4.  The unfolded von Willebrand factor response in bloodstream: the self-association perspective.

Authors:  Hailong Yuan; Ning Deng; Songmei Zhang; Yange Cao; Qiong Wang; Xin Liu; Qing Zhang
Journal:  J Hematol Oncol       Date:  2012-10-15       Impact factor: 17.388

5.  Synthesis and characterization of different immunogenic viral nanoconstructs from rotavirus VP6 inner capsid protein.

Authors:  Francesca Bugli; Valeria Caprettini; Margherita Cacaci; Cecilia Martini; Francesco Paroni Sterbini; Riccardo Torelli; Stefano Della Longa; Massimiliano Papi; Valentina Palmieri; Bruno Giardina; Brunella Posteraro; Maurizio Sanguinetti; Alessandro Arcovito
Journal:  Int J Nanomedicine       Date:  2014-05-30

6.  Platelet adhesion and aggregate formation controlled by immobilised and soluble VWF.

Authors:  Matthias F Schneider; Mohammad A Fallah; Christian Mess; Tobias Obser; Reinhard Schneppenheim; Alfredo Alexander-Katz; Stefan W Schneider; Volker Huck
Journal:  BMC Mol Cell Biol       Date:  2020-09-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.